Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT04176224 is registered in ClinicalTrials.gov with Shionogi as lead sponsor.

NCT NCT04176224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04176224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis (ALS)
Lead sponsor
Shionogi
Phase
Phase 1
Overall status
Completed
Start date
April 17, 2019
Completion date
September 4, 2019
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

japanese patients with als